April 26, 2023
The U.S. Department of Justice told the Fifth Circuit on Wednesday that a Texas federal court abused its discretion by issuing an order that would have blocked access to a common abortion medication had the U.S. Supreme Court not stepped in to stop it.
April 19, 2023
U.S. Supreme Court Justice Samuel Alito on Wednesday further stayed lower courts' decisions to block access to a widely used abortion medication after the U.S. Department of Justice, pharmaceutical executives and former U.S. Food and Drug Administration officials warned that allowing courts to upend the FDA's approval would elicit regulatory chaos.
April 13, 2023
The Fifth Circuit's midnight order to partly uphold an intensely controversial decision restricting access to a widely used abortion medication has teed up another potential U.S. Supreme Court battle over women's health care and unleashed a host of questions about the ability of abortion opponents to bring suits over U.S. Food and Drug Administration and other science-driven policymaking.
April 13, 2023
The U.S. Department of Justice said Thursday it intends to seek emergency relief from the U.S. Supreme Court following a Fifth Circuit decision that stayed a Texas judge's order to halt sales of the abortion pill mifepristone, but cuts off access to telehealth abortion care and bars the distribution of the pill by mail.
April 12, 2023
The Fifth Circuit late Wednesday temporarily blocked a Texas federal judge's decision to halt nationwide sales of the most commonly used abortion medication, but also refused to stay the judge's rejection of U.S. Food and Drug Administration policy changes that streamlined access to the medication.
April 11, 2023
Nationwide access to a widely used abortion pill could be cut off as early as Friday if a Texas federal judge's order blocking the U.S. Food and Drug Administration's decades-old approval of mifepristone takes effect, but appellate experts say even the Fifth Circuit's conservative judges may not be convinced that the anti-abortion plaintiffs that brought the case have standing.
April 11, 2023
Two hundred and forty members of Congress, including nearly every Democrat in the Senate, filed an amicus brief Tuesday urging the Fifth Circuit to stay last week's district court order blocking the U.S. Food and Drug Administration's decades-old approval of the abortion drug mifepristone.
April 10, 2023
The U.S. Department of Justice told the Fifth Circuit on Monday that the anti-abortion groups and physicians who sued to undo the U.S. Food and Drug Administration's 23-year-old approval of the abortion pill mifepristone lack standing and urged the court to halt a Texas federal judge's order blocking medication abortion access nationwide starting Friday.